Sanofi (SNY)
Sanofi Statistics
Share Statistics
Sanofi has 2.50B shares outstanding. The number of shares has increased by -0.49% in one year.
| Shares Outstanding | 2.50B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.45% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.50B |
| Failed to Deliver (FTD) Shares | 972 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 3.74M, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 3.74M |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.15% |
| Short Ratio (days to cover) | 1.53 |
Valuation Ratios
The PE ratio is 20.81 and the forward PE ratio is 10.07. Sanofi's PEG ratio is 1.12.
| PE Ratio | 20.81 |
| Forward PE | 10.07 |
| PS Ratio | 2.44 |
| Forward PS | 2.5 |
| PB Ratio | 1.52 |
| P/FCF Ratio | 15.53 |
| PEG Ratio | 1.12 |
Enterprise Valuation
Sanofi has an Enterprise Value (EV) of 122.06B.
| EV / Earnings | 22.6 |
| EV / Sales | 2.65 |
| EV / EBITDA | 10.17 |
| EV / EBIT | 15.5 |
| EV / FCF | 16.87 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.27 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.25 |
| Total Debt / Capitalization | 19.92 |
| Cash Flow / Debt | 0.56 |
| Interest Coverage | 7.2 |
Financial Efficiency
Return on equity (ROE) is 0.07% and return on capital (ROIC) is 6.59%.
| Return on Equity (ROE) | 0.07% |
| Return on Assets (ROA) | 0.04% |
| Return on Capital (ROIC) | 6.59% |
| Revenue Per Employee | 534.72K |
| Profits Per Employee | 62.73K |
| Employee Count | 86.09K |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.47 |
Taxes
| Income Tax | 1.60B |
| Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 5.71% in the last 52 weeks. The beta is 0.45, so Sanofi's price volatility has been higher than the market average.
| Beta | 0.45 |
| 52-Week Price Change | 5.71% |
| 50-Day Moving Average | 48.78 |
| 200-Day Moving Average | 51.09 |
| Relative Strength Index (RSI) | 73.84 |
| Average Volume (20 Days) | 2.39M |
Income Statement
In the last 12 months, Sanofi had revenue of 46.03B and earned 5.40B in profits. Earnings per share was 4.31.
| Revenue | 46.03B |
| Gross Profit | 31.80B |
| Operating Income | 7.88B |
| Net Income | 5.40B |
| EBITDA | 12.00B |
| EBIT | 7.88B |
| Earnings Per Share (EPS) | 4.31 |
Balance Sheet
The company has 8.71B in cash and 18.42B in debt, giving a net cash position of -9.71B.
| Cash & Cash Equivalents | 8.71B |
| Total Debt | 18.42B |
| Net Cash | -9.71B |
| Retained Earnings | 67.50B |
| Total Assets | 129.75B |
| Working Capital | 52.00M |
Cash Flow
In the last 12 months, operating cash flow was 10.26B and capital expenditures -3.02B, giving a free cash flow of 7.23B.
| Operating Cash Flow | 10.26B |
| Capital Expenditures | -3.02B |
| Free Cash Flow | 7.23B |
| FCF Per Share | 5.78 |
Margins
Gross margin is 69.07%, with operating and profit margins of 17.11% and 11.73%.
| Gross Margin | 69.07% |
| Operating Margin | 17.11% |
| Pretax Margin | 15.54% |
| Profit Margin | 11.73% |
| EBITDA Margin | 26.06% |
| EBIT Margin | 17.11% |
| FCF Margin | 15.71% |
Dividends & Yields
SNY pays an annual dividend of $2.2, which amounts to a dividend yield of 4.19%.
| Dividend Per Share | $2.20 |
| Dividend Yield | 4.19% |
| Dividend Growth (YoY) | 7.83% |
| Payout Ratio | 117.65% |
| Earnings Yield | 8.11% |
| FCF Yield | 5.45% |
Analyst Forecast
The average price target for SNY is $60, which is 12.9% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60 |
| Price Target Difference | 12.9% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Sep 30, 2013. It was a forward split with a ratio of 5:1.
| Last Split Date | Sep 30, 2013 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | 2.7 |
| Piotroski F-Score | 8 |